United Kingdom, 22 April 2021 - A test which uses artificial intelligence (AI) to measure proteins present in some patients with advanced bowel cancer could hold the key to more targeted treatment, according to research...

Partnership to leverage Illumina's extensive decentralised installed base with Roche's expertise in assay development and to provide broad access to clinical oncology next-generation sequencing Comprehensive genomic testing improves...